Shire Sues Barr Over Kidney Drug ANDA

Law360, New York (March 16, 2009, 12:00 AM EDT) -- Barr Laboratories Inc. has been hit by Shire PLC with an infringement suit after filing an abbreviated new drug application for a generic version of Shire's kidney drug Fosrenol.

The suit, filed Monday in the U.S. District Court for the Southern District of New York, alleges that Barr, now part of Teva Pharmaceutical Industries Ltd., infringed three patents held by Shire.

Shire filed the suit in response to Barr’s ANDA seeking U.S. Food and Drug Administration approval to market and sell generic versions of Shire's 500...
To view the full article, register now.